Dr. Jeffrey P. Koplan will join the Yale Corporation as an Alumni Fellow for a six-year term beginning July 1, University President Richard C. Levin has announced. Koplan is vice president for Academic Health Affairs at Emory University and former...
Bayer Pharmaceuticals Corporation has created a $2 million endowment to help advance cutting-edge medical research at Yale School of Medicine. Through this new program, called the Bayer Endowment for Scholars in Medicine and Management, a fellowship...
A Yale researcher who studies the molecular biology of the Epstein-Barr virus (EBV), which is linked to many cancers such as Hodgkin’s and non-Hodgkin’s lymphoma, has received a $2.1 million, five-year award from the National Institutes of Health (NIH...
The goal of “Overcoming Dyslexia,” a new book by Yale School of Medicine researcher Sally Shaywitz, M.D., is to translate groundbreaking research on the disorder, including brain imaging studies, into practical methods and programs that can be used by...
Investigators at Yale and Oxford University have been awarded over $3.3 million from the National Institute of Allergy and Infectious Diseases for a five-year study to investigate the genetic and environmental risk factors that increase susceptibility...
Elizabeth Bradley, associate professor in the Department of Epidemiology and Public Health at Yale School of Medicine, has become the first Yale researcher to win the John D. Thompson Prize for Young Investigators. The prize will be presented in June...
Yale School of Medicine will celebrate the opening of 300 Cedar St., its newest research and education building, on May 2. National Institutes of Health (NIH) Director Elias Zerhouni, M.D., will lead the celebration with a keynote address at 3:30 p.m...
When older patients followed a non-drug intervention strategy for preventing delirium, their rates of delirium were lowered by as much as 89 percent, Yale researchers report in the April 28 issue of Archives of Internal Medicine. “It has been well-...
In light of current world events, Yale School of Nursing (YSN) will host a public forum to address how religious diversity and tolerance affect health care in our community on April 24, at 5:30 p.m. in room 118, YSN, 100 Church St. South. David Shaheed...
A study by Yale researchers suggests that the atypical antipsychotic drug risperidone reduces tic symptoms in children and adults with Tourette syndrome (TS). “These results suggest that risperidone is safe and effective for short-term treatment of tics...